DRIO Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (24 Apr 2024 @ 16:00):

Stats
Today's Volume	39 413.00
Average Volume	132 827
Market Cap	44.16M
EPS	$0 ( 2024-03-28 )
Next earnings date	( $-0.590 ) 2024-05-09
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.780
ATR14	$0.00900 (0.60%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-06	Ben-david Zvi	Buy	400 000	Common Stock
2024-03-06	Shaked Yoav	Buy	90 000	Common Stock
2024-03-06	Anderson Richard Alan	Buy	750 000	Stock Option (right to buy)
2024-03-06	Anderson Richard Alan	Buy	320 000	Stock Option (right to buy)
2024-03-06	Kaplan Jon H.	Buy	70 000	Common Stock

INSIDER POWER
99.69
Last 96 transactions
Buy: 6 562 105 \| Sell: 542 820

Volume Correlation

Long: -0.07 (neutral)

Short: 0.36 (neutral)

Signal:(63.415) Neutral

DarioHealth Corp Correlation

10 Most Positive Correlations
SVAC	0.909
SRTS	0.905
PASG	0.904
BLZE	0.886
CPIX	0.882
ENG	0.881
QRTEA	0.875
SWVL	0.874
CDXC	0.874
ITOS	0.873

10 Most Negative Correlations
AMRB	-0.908
MMAC	-0.886
LWAC	-0.882
XOG	-0.866
NETE	-0.866
ISEM	-0.864
SGEN	-0.863
LMNR	-0.845
SRAC	-0.843
AAON	-0.839

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

DarioHealth Corp Correlation - Currency/Commodity

-0.25
( neutral )

-0.29
( neutral )

0.00
( neutral )

0.08
( neutral )

-0.12
( neutral )

0.37
( neutral )

DarioHealth Corp Financials

Annual	2023
Revenue:	$20.35M
Gross Profit:	$5.98M (29.40 %)
EPS:	$-1.930

Q4	2023
Revenue:	$3.62M
Gross Profit:	$132 000 (3.65 %)
EPS:	$-0.440

Q3	2023
Revenue:	$3.52M
Gross Profit:	$610 000 (17.34 %)
EPS:	$0.590

Q2	2023
Revenue:	$6.15M
Gross Profit:	$2.07M (33.71 %)
EPS:	$-0.590

Financial Reports:

No articles found.

DarioHealth Corp

DarioHealth Corp. operates as a digital therapeutics company in the United States, Canada, the European Union, Australia, and New Zealand. The company offers Dario's metabolic solutions to address metabolic health needs, such as diabetes, hypertension, and weight management; Dario Musculoskeletal, which helps to prevent and treat the most common MSK conditions; Dario's behavioral health solution that optimizes access to evidence-based care; chronic condition management solutions; DarioEngage, a proprietary care management platform; and device-specific disposables test strip cartridges, lancets, and blood glucose monitoring systems. It also provides smart glucose meters; bluetooth connected blood pressure cuff; digital scales; biofeedback sensor devices; and diabetes management programs, including lifestyle changes, healthy eating, advanced tracking, and live coaching. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was incorporated in 2011 and is based in New York, New York.